These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35065293)

  • 1. Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine.
    Shi C; Pei M; Wang Y; Chen Q; Cao P; Zhang L; Guo J; Deng W; Wang L; Li X; Gong Z
    Biochem Biophys Res Commun; 2022 Feb; 594():1-7. PubMed ID: 35065293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.
    Zhu W; Buffa JA; Wang Z; Warrier M; Schugar R; Shih DM; Gupta N; Gregory JC; Org E; Fu X; Li L; DiDonato JA; Lusis AJ; Brown JM; Hazen SL
    J Thromb Haemost; 2018 Sep; 16(9):1857-1872. PubMed ID: 29981269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota metabolite trimethylamine N-oxide promoted NAFLD progression by exacerbating intestinal barrier disruption and intrahepatic cellular imbalance.
    Nian F; Chen Y; Xia Q; Zhu C; Wu L; Lu X
    Int Immunopharmacol; 2024 Dec; 142(Pt B):113173. PubMed ID: 39298816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3.
    Lang DH; Yeung CK; Peter RM; Ibarra C; Gasser R; Itagaki K; Philpot RM; Rettie AE
    Biochem Pharmacol; 1998 Oct; 56(8):1005-12. PubMed ID: 9776311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular reactivity stimulated by TMA and TMAO: Are perivascular adipose tissue and endothelium involved?
    Restini CBA; Fink GD; Watts SW
    Pharmacol Res; 2021 Jan; 163():105273. PubMed ID: 33197599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary phenolics and their microbial metabolites are poor inhibitors of trimethylamine oxidation to trimethylamine N-oxide by hepatic flavin monooxygenase 3.
    Iglesias-Carres L; Chadwick-Corbin SA; Sweet MG; Neilson AP
    J Nutr Biochem; 2023 Oct; 120():109428. PubMed ID: 37549832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far?
    Coutinho-Wolino KS; de F Cardozo LFM; de Oliveira Leal V; Mafra D; Stockler-Pinto MB
    Eur J Nutr; 2021 Oct; 60(7):3567-3584. PubMed ID: 33533968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneously hypertensive rats exhibit increased liver flavin monooxygenase expression and elevated plasma TMAO levels compared to normotensive and Ang II-dependent hypertensive rats.
    Gawryś-Kopczyńska M; Szudzik M; Samborowska E; Konop M; Chabowski D; Onyszkiewicz M; Ufnal M
    Front Physiol; 2024; 15():1340166. PubMed ID: 38681141
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of three oral pathogens on the TMA-TMAO metabolic pathway.
    Wang X; Chen L; Teng Y; Xie W; Huang L; Wu J; Wang H; Xie S
    Front Cell Infect Microbiol; 2024; 14():1413787. PubMed ID: 38836053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible correlation between high circulatory levels of trimethylamine-N-oxide and 2177G>C polymorphisms of hepatic flavin containing monooxygenase 3 in Kurdish Population with non-alcoholic fatty liver disease.
    Moradzad M; Abdi M; Sheikh Esmaeili F; Ghaderi D; Rahmani K; Moloudi MR; Vahabzadeh Z
    Mol Biol Rep; 2022 Jul; 49(7):5927-5937. PubMed ID: 35348964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats.
    Zhao ZH; Xin FZ; Zhou D; Xue YQ; Liu XL; Yang RX; Pan Q; Fan JG
    World J Gastroenterol; 2019 May; 25(20):2450-2462. PubMed ID: 31171889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota-derived trimethylamine-N-oxide: A bridge between dietary fatty acid and cardiovascular disease?
    He M; Tan CP; Xu YJ; Liu Y
    Food Res Int; 2020 Dec; 138(Pt B):109812. PubMed ID: 33288187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.
    Fennema D; Phillips IR; Shephard EA
    Drug Metab Dispos; 2016 Nov; 44(11):1839-1850. PubMed ID: 27190056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethylamine-N-Oxide Pathway: A Potential Target for the Treatment of MAFLD.
    Li X; Hong J; Wang Y; Pei M; Wang L; Gong Z
    Front Mol Biosci; 2021; 8():733507. PubMed ID: 34660695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota metabolite TMAO promoted lipid deposition and fibrosis process via KRT17 in fatty liver cells in vitro.
    Nian F; Zhu C; Jin N; Xia Q; Wu L; Lu X
    Biochem Biophys Res Commun; 2023 Aug; 669():134-142. PubMed ID: 37271025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease.
    Tan X; Liu Y; Long J; Chen S; Liao G; Wu S; Li C; Wang L; Ling W; Zhu H
    Mol Nutr Food Res; 2019 Sep; 63(17):e1900257. PubMed ID: 31095863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation.
    Bennett BJ; de Aguiar Vallim TQ; Wang Z; Shih DM; Meng Y; Gregory J; Allayee H; Lee R; Graham M; Crooke R; Edwards PA; Hazen SL; Lusis AJ
    Cell Metab; 2013 Jan; 17(1):49-60. PubMed ID: 23312283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Measurement of Urinary Trimethylamine (TMA) and Trimethylamine
    Jia X; Osborn LJ; Wang Z
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32316639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of a Gut Microbial-Derived Metabolite, Trimethylamine N-Oxide (TMAO), in Neurological Disorders.
    Praveenraj SS; Sonali S; Anand N; Tousif HA; Vichitra C; Kalyan M; Kanna PV; Chandana KA; Shasthara P; Mahalakshmi AM; Yang J; Pandi-Perumal SR; Sakharkar MK; Chidambaram SB
    Mol Neurobiol; 2022 Nov; 59(11):6684-6700. PubMed ID: 35986843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethylamine, a gut bacteria metabolite and air pollutant, increases blood pressure and markers of kidney damage including proteinuria and KIM-1 in rats.
    Maksymiuk KM; Szudzik M; Gawryś-Kopczyńska M; Onyszkiewicz M; Samborowska E; Mogilnicka I; Ufnal M
    J Transl Med; 2022 Oct; 20(1):470. PubMed ID: 36243862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.